The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Korean Herbal Medicine that Function by Inducing Diuresis for Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials

고혈압에 대한 한약 이수 처방 효과에 대한 체계적 문헌 고찰 및 메타분석

  • Kang, Ja-yeon (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University) ;
  • Kang, Ki-wan (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University) ;
  • Jeong, Min-jeong (Dept. of Pediatrics, College of Korean Medicine, Woo-Suk University) ;
  • Kim, Hong-jun (Dept. of Prescription, College of Korean Medicine, Woo-Suk University) ;
  • Jan, In-soo (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University)
  • 강자연 (우석대학교 한의과대학 한방내과학교실) ;
  • 강기완 (우석대학교 한의과대학 한방내과학교실) ;
  • 정민정 (우석대학교 한의과대학 소아과학교실) ;
  • 김홍준 (우석대학교 한의과대학 방제학교실) ;
  • 장인수 (우석대학교 한의과대학 한방내과학교실)
  • Received : 2017.09.22
  • Accepted : 2017.11.20
  • Published : 2017.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The aim of this study was to review the clinical research on antihypertensive effects of Korean herbal medicines that function by inducing diuresis. Methods: Literature searches were performed using PubMed, Cochrane, CNKI, Wanfang, Cinii, Oasis, KISS, NDSL, RISS, DBPia, with the keywords "利水", "利尿", "高血壓", "hypertension", and "lishui." The search range included only randomized controlled trials that verified the effects of Korean herbal medicine interventions on hypertension. The selected studies were assessed by risk of bias (RoB). Results: 26 reports were selected from a total of 532 identified. For these reports, meta-analysis was performed using Revman 5.3. From this analysis, it was observed that the combined treatment of Korean medicine and antihypertensive drugs had a significantly higher total effective rate (TER) and improvement in systolic blood pressure (SBP) and diastolic blood pressure (DBP) than did the use of a single antihypertensive drug. The risk ratio of TER for lowering blood pressure was 1.25. The mean differences of SBP, DBP were -19.63 mm Hg (95% confidential interval (CI), -22.45 mm Hg, -16.80 mm Hg, p<0.00001), and -5.39 mm Hg (95% CI, -7.36 mm Hg, -3.42 mm Hg, p<0.00001) respectively. The use of Korean medicine only did not improve blood pressure, as compared to the use of an antihypertensive drug. Most of items of RoB were unclear, and the methodological quality was low. Conclusions: The combination of antihypertensive drugs and Korean medical treatment can effectively improve SBP, DBP, and TER. This finding could be widely utilized in clinical practice in Korean medicine.

Keywords

References

  1. Ministry of health and Welfare. Korean Centers for Disease control & Prevention. 2015 Health Behavior and Chronic Disease Statistics. Seoul: Ministry of health and Welfare; 2016, p. 22-3.
  2. Seoul Asan Hospital internal Medicine. 2016 Recent advances in internal medicine. Seoul: Our medical books; 2016, p. 34-6.
  3. The board of establishing guideline for diagnosis in the Korean society of hypertension. Guideline for the diagnosis and management of hypertension in the Korean society of hypertension. Seoul: Ibplanning; 2013, p. 33-7.
  4. Association of Korean Medicine Professors for Cardiovascular and Neurological Medicine. Cardiovascular and neurological medicine in Korean medicine II-cardiovascular Medicine. Seoul: Uri medical books; 2016, p. 366-91.
  5. Lee HY, Kang KW, Lee E, Lee SH, Han CH, Jang IS. A systematic review on antihypertensive effects of oryeong-san. J of Internal Korean Medicine 2013;34(3):289-97.
  6. Jang IS, Kim MJ, Han HJ, Jeoung MJ, Kang SY. Treatment of primary hypertension by oryung-san monotherapy: a case report. J of Internal Korean Medicine 2014;35(1):106-10.
  7. Wu ZH. Clinical effective observation on treating renal damage in early hypertension with the compound Chinese herbal medicine of blood-activating and urine-inducing. J of Traditional Chinese Medicine 2017;3:109-10.
  8. Huang HM. Effect Analysis of Dialectical prescription in treatment of hypertension in Traditional Chinese Medicine principle. China Health Standards Management 2016;7(4):137-8.
  9. Wang SH. Clinical observation of Chinese Medicine Lishui-Tongluo treatment on hypertension. Chinese J of Traditional Chinese Medicine and Materia Medica 2016;37(8):49-50.
  10. Yang YM. Clinical observation on inducing diuresis in hypertension treatment. J of Application of Integrative Medicine 2016;16(5):41-2.
  11. Sun JH. Clinical effective observation of Chinese Medicine Lishui-Tongluo treatment on hypertension. J of Inner Mongolian Medicine 2016;9:52.
  12. Liu LX. A Clinical analysis of treating 120 cases hypertension by the Lishui therapy plus western medicine. Clinical J of Chinese Medicine 2016; 8(13):92-3.
  13. Jiang H, Qian LC, Zhou RM, Xi SY, Yang ZB, Peng L, et al. Observation on curative effect of Chinese Medicine in treating hypertension. Jangxi of Tradidional Chinese Medicine 2016;47(400):39-41.
  14. Qi BY. Clinical observation on hypertension treated by Chinese Medicine diuresis. J of Sichuan of Traditional Chinese Medicine 2015;33(9):85-8.
  15. Li D. Clinical analysis of Chiniese Medicine assisted adjuvant therapy for hypertension. Asai-Pacific Traditional Medicine 2015;11(1):104-5.
  16. Liu Q. A Clinical analysis of treating 55 cases hypertension by the Lishui treatment. For all Health 2015;9(1):81-2.
  17. Chen Q. Clinical study on treatment of hypertension with Chinese Medicine diuresis. China J Ctrl Endem Dis 2014;29(2):63.
  18. Zhang Z, Zhang FJ. A Clinical analysis of Chiniese Medicine assisted adjuvant therapy for hypertension. J of Inner Mogolian Medicine 2014;27:7-8.
  19. Wang WB. Clinical observation on hypertension by Chinese Medicine Lishui treatment. Asai-Pacific Traditional Medicine 2014;10(23):69.
  20. Yang N. Clinical study of treating 68 hypertension cases by the Lishui treatment. Chinese Medicine Modern Distance Education of China 2014;12(12):130-1.
  21. Qian G. Analysis of Traditional Chinese Medicine diuresis in hypertensive patients. Guide of China Medicine 2013;11(35):514-5.
  22. Zhang YF. Randomized study of Traditional Chinese Medicine and water decoction in the treatment of hypertension. J of Practical Traditional Chinese Internal Medicine 2013;27(7):32-3.
  23. Qian HL, Guo P, Zeng ZP. Observation on the efficacy of integrated Traditional Chinese and western medicine in the treatment of elderly patients with systolic hypertension. Henan Traditional Chinese Medicine 2010;30(8):790-1.
  24. Zhen YH. Clinical observation on 48 cases of hypertension treated by HuanglongSararyongtang. Fujian J of TCM 2009;40(1):6-7.
  25. Li DR. Clinical observation on 62 cases of Elderly Hypertension treated by Chinese medicine. J of Zhejiang Traditional Chinese Medicine 2003:201-2.
  26. Zhang WP. Clinical Analysis of treatment of essential hypertension by herbal medicine. Primary Medicine Forum 2016;20(8):1097-8.
  27. Su Q. Chinese Medicine diuresis with clinical analysis of the treatment of hypertension. J of Northern Pharmacy 2016;13(4):12-3.
  28. Zhang XZ. Clinical observation on inducing diuresis therapy combined with western medicine in the treatment of hypertension. Chinese Medicine Modern Distance Education of China 2016;14(18):53-5.
  29. Wu J. Clinical analysis of Chineses Medicine in treating hypertension. For all Health 2015;9(6):36-7.
  30. Shen RH. Clinical observation on treatment of hypertension by Traditional Chinese Medicine. China's rural Health 2016;2:16.
  31. Peng YC, Zhao J. Clinical efficacy of hypertensive patients in the treatment of traditional Chinese medicine Diuresis. For all Health 2015;9(4):314.
  32. Li YS, Sun GL. Clinical study on treatment of hypertension with Wuling Powder. Chin J of Clinical Rational Drug Use 2016;9(6):57-8.
  33. National Health Insurance Service, Health Insurance Review & Assessment Service. 2014 National Health Insurance Statistical Yearbook. Seoul: Jisung; 2015, p. 61-3.
  34. Park JE, Kwon SM. Determinants of the utilization of oriental medical services by the Elderly. J of Korean Oriental Medicine 2011;32(1):97-108.
  35. Kang JY, Kang KW, Jeong MJ, Kim HJ, Jang IS. A Study on survey of Hypertension Treatment in Korean Medicine. J of Internal Korean Medicine 2016;37(6):1022-9. https://doi.org/10.22246/jikm.2016.37.6.1022
  36. Han IS, Shin JH, Cho YY, Park HM, Yang CS, Jeong MJ, et al. Qu-Ji-Du-Huang-Wan for Essential Hypertension : Systemic Review and Meta-analysis. J Physiol & Pathol Korean Med 2017;31(2):118-25. https://doi.org/10.15188/kjopp.2017.04.31.2.118
  37. Association of Korean Medicine Professors for Cardiovascular and Neurological Medicine. Cardiovascular and neurological medicine in Korean medicine I. Seoul: Uri medical books; 2016, p. 196-9.
  38. Utsuki S, Oka H, Inukai M, Abe K, Fujii K. Role of saireito in postoperative chronic subdural hematoma recurrence prevention. J Trad Med 2012;29(3):137-42.
  39. Jeong YK, Kim SB, Yang JY, Moon SK, Jung WS, Kwon SW, et al. Two case studies of the use of Oreong-san for a chronic subdural hematoma. J of Internal Korean Medicine 2017;38(2):259-26. https://doi.org/10.22246/jikm.2017.38.2.259

Cited by

  1. 혈부축어탕의 본태성 고혈압에 대한 치료 효과 관한 메타 분석 및 체계적 고찰 vol.39, pp.6, 2017, https://doi.org/10.22246/jikm.2018.39.6.1150